High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancerAre high-risk patients good candidates?Hochdosierte interstitielle Brachytherapie in Kombination mit einer Androgendeprivationstherapie beim ProstatakarzinomSind Hochrisiko-Patienten gute Kandidaten?

被引:0
作者
Ken Yoshida
Hideya Yamazaki
Tadashi Takenaka
Tadayuki Kotsuma
Mineo Yoshida
Koji Masui
Yasuo Yoshioka
Yoshifumi Narumi
Toshitsugu Oka
Eiichi Tanaka
机构
[1] Osaka Medical College,Department of Radiology
[2] Kyoto Prefectural University of Medicine,Department of Radiology
[3] National Hospital Organization Osaka National Hospital,Department of Radiology
[4] National Hospital Organization Osaka National Hospital,Department of Radiation Oncology
[5] Osaka University Graduate School of Medicine,Department of Radiation Oncology
[6] National Hospital Organization Osaka National Hospital,Department of Urology
来源
Strahlentherapie und Onkologie | 2014年 / 190卷
关键词
Survival; Radiotherapy; Quality of life; Toxicity; Monotherapy; Überleben; Radiotherapie; Lebensqualität; Toxizität; Monotherapie;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1015 / 1020
页数:5
相关论文
共 67 条
[1]  
Barkati M(2012)High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial Int J Radiat Oncol Biol Phys 82 1889-1896
[2]  
Williams SG(2012)High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer Br J Radiol 85 18-27
[3]  
Foroudi F(2011)High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 81 1286-1292
[4]  
Challapalli A(2002)Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 81-90
[5]  
Jones E(2009)Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy Brachytherapy 8 45-51
[6]  
Harvey C(2004)High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds J Urol 171 1098-1104
[7]  
Demanes DJ(2012)High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence Int J Radiat Oncol Biol Phys 82 1376-1384
[8]  
Martinez AA(2005)Role of prostate dose escalation in patients with greater than 15 % risk of pelvic lymph node involvement Int J Radiat Oncol Biol Phys 61 695-701
[9]  
Ghilezan M(2013)Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy Int J Urol 20 185-192
[10]  
Galalae RM(2005)GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer Radiother Oncol 74 137-148